PerkinElmer - Developing Products in China for China

Posted: 7 Mar 2012

See all articles by Vicki Sato

Vicki Sato

Harvard University

Christoph Jaeker

Harvard University - Business School (HBS)

Kareem Reda

Harvard University - Business School (HBS)

Date Written: December 16, 2011

Abstract

Sym-Bio, an entrepreneurial Chinese diagnostic company with a product line in infectious disease testing, has agreed to be acquired by PerkinElmer, an international corporation with businesses in neonatal testing, life science services, and environmental health. Sym-Bio wants to accelerate its growth and competitive position in China through this strategic move, and PerkinElmer seeks to broaden its access to the Chinese marketplace, leverage the cost advantages of operating in China, and tap into the talent pool of young Chinese scientists. Strategic and operational integration of Sym-Bio into PerkinElmer is explored through the lens of the founder and CEO of Sym-Bio and that of the acquiring company.

Learning Objective: Examine a market entry strategy for the Chinese market.

Suggested Citation

Sato, Vicki and Jaeker, Christoph and Reda, Kareem, PerkinElmer - Developing Products in China for China (December 16, 2011). Harvard Business School Technology & Operations Mgt. Unit Case No. 612-032, Available at SSRN: https://ssrn.com/abstract=2017801

Vicki Sato (Contact Author)

Harvard University ( email )

1875 Cambridge Street
Cambridge, MA 02138
United States

Christoph Jaeker

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Kareem Reda

Harvard University - Business School (HBS) ( email )

Soldiers Field Road
Morgan 270C
Boston, MA 02163
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Abstract Views
632
PlumX Metrics